ing).4 Similar ring-formation order was employed in a
number of more recent syntheses, including those highlight-
ing modern C-H-functionalization tactics reported by the
groups of Gaunt (rhazinicine),5 Sames,6 and Trauner.7 The
synthesis developed by Magnus and Rainey in 2001 illustrates
a new method for pyrrole synthesis and avoids the C5-protection
of the heterocycle.8 A gold(I)-catalyzed allene annulation was
utilized by the group of Nelson in 2006 to accomplish an
enantioselective total synthesis of rhazinilam.9 In the same year,
Banwell and co-workers described the synthesis of (-)-
rhazinilam and (-)-rhazinal capitalizing on enantioselective
electrophilic pyrrole alkylation under imminium-ion catalysis
to form the tetrahydroindolizine fragment.10
an initial study of the transannular cyclization, unveiling 13-
membered macrolactam 4 as a key precursor. We anticipated
that a variety of chiral ligands available for palladium would
eventually allow for the development of an enantioselective
version of the palladium-catalyzed transannular reaction.13
In practice, the pursuit of this synthesis plan provided an
unexpected insight into the stereochemistry of advanced
macrocyclic intermediates offering a distinct approach to
enantioselective synthesis of rhazinilam alkaloids in the
future.
The synthesis of macrolactam 4 began with the preparation
of 2-(1H-pyrrol-3-yl)aniline (8) following a literature pre-
cedent.14 Borylation of 3-bromo-N-triisopropylsilylpyrrole
(5) with pinacolborane (1.2 equiv) in the presence of
bis(acetonitrile)palladium dichloride (3 mol %) and S-Phos
(9 mol %) provided boronate 6 (Scheme 2). Cross-coupling
Strategically, all of these syntheses share a sequential ring-
formation approach starting with the assembly of the
tetrahydroindolizine ring system and concluding with the
formation of the nine-membered lactam.
Considering various options in the synthesis design, we
became intrigued by the potential of a transannular cycliza-
tion outlined in Scheme 1 to achieve the installation of the
Scheme 2. Synthesis of 2-(1H-Pyrrol-3-yl)aniline (8)
Scheme 1
.
Transannular Disconnection in the Synthesis of
Rhazinilama
of 6 with 2-iodoaniline was achieved with the same ligand
(S-Phos, 8 mol %), palladium acetate (4 mol %), and
potassium phosphate in aqueous 1-butanol in 91% yield.
Removal of the triisopropylsilyl group was carried out under
basic conditions (MeONa, methanol, reflux) to complete the
synthesis of 8 in 92% yield.15
a M ) transition metal.
quaternary stereogenic center, the nine-membered lactam,
and the tetrahydroindolizine ring system in a single bond-
forming event. Transannular cyclizations have been recog-
nized as a powerful approach in the synthesis of polycyclic
ring systems.11 A transition-metal-catalyzed process such as
a Heck reaction12 was identified as a preferred method for
The preparation of iodoolefin 13 was initiated by the
Michael addition of 2,4-pentanedione to tert-butyl acrylate
upon treatment with potassium carbonate at 70 °C (Scheme
3). The resulting 1,3-diketone was exposed to aqueous
formaldehyde under basic conditions producing enone 10 in
77% yield after a cascade condensation-fragmentation
process.16 Luche reduction (NaBH4, CeCl3·7H2O, MeOH)17
followed by acetylation gave 11, which served as a substrate
for subsequent Ireland-Claisen rearrangement forming acid
12 in 71% yield.18 Selective reduction of 12 followed by
iododehydroxylation provided iodide 13 in 79% overall yield.
Preceding the macrolactam formation, a regioselective
halogenation at the C2 position of 2-(1H-pyrrol-3-yl)aniline
(8) was required. This type of selective functionalization is
useful for the synthesis of a variety of bioactive compounds
(4) Ratcliffe, A. H.; Smith, G. F.; Smith, G. N. Tetrahedron Lett. 1973,
14, 5179–5184.
(5) Beck, E. M.; Hatley, R.; Gaunt, M. J. Angew. Chem., Int. Ed. 2008,
47, 3004–3007.
(6) (a) Johnson, J. A.; Sames, D. J. Am. Chem. Soc. 2000, 122, 6321–
6322. (b) Johnson, J. A.; Li, N.; Sames, D. J. Am. Chem. Soc. 2002, 124,
6900–6903.
(7) (a) Bowie, A. L.; Hughes, C. C.; Trauner, D. Org. Lett. 2005, 7,
5207–5209. (b) Bowie, A. L.; Trauner, D. J. Org. Chem. 2009, 74, 1581–
1586.
(8) Magnus, P.; Rainey, T. Tetrahedron 2001, 57, 8647–8651.
(9) Liu, Z.; Wasmuth, A. S.; Nelson, S. G. J. Am. Chem. Soc. 2006,
128, 10352–10353.
(10) (a) Banwell, M. G.; Beck, D. A. S.; Willis, A. C. ARKIVOC 2006,
163–174. (b) Banwell, M. G.; Edwards, A. J.; Jolliffe, K. A.; Smith, J. A.;
Hamel, E.; Verdier-Pinard, P. Org. Biomol. Chem. 2003, 1, 296–305.
(11) For recent examples, see: (a) Balskus, E. P.; Jacobsen, E. N. Science
2007, 317, 1736. (b) Bodwell, G. J.; Li, J. Angew. Chem., Int. Ed. 2002,
41, 3261–3262. (c) Chandler, C. L.; List, B. J. Am. Chem. Soc. 2008, 130,
6737–6739. (d) Dalgard, J. E.; Rychnovsky, S. D. Org. Lett. 2004, 6, 2713–
2716. (e) Basak, A.; Roy, S. K.; Mandal, S. Angew. Chem., Int. Ed. 2005,
44, 132–135.
(13) Dounay, A. B.; Overman, L. E. Chem. ReV. 2003, 103, 2945–2963.
(14) Morrison, M. D.; Hanthorn, J. J.; Pratt, D. A. Org. Lett. 2009, 11,
1051–1054.
(15) Chan, H.-W.; Chan, P.-C.; Liu, J.-H.; Wong, H. N. C. Chem.
Commun. 1997, 1515–1516.
(16) Kalaus, G.; Juha´sz, I.; Greiner, I.; Kajtar-Peredy, M.; Brlik, J.;
Szabo´, L.; Sza´ntay, C. J. Org. Chem. 1997, 62, 9188–9191.
(17) Gemal, A. L.; Luche, J.-L. J. Org. Chem. 1979, 44, 4187–4189.
(18) (a) Ireland, R. E.; Mueller, R. H. J. Am. Chem. Soc. 1972, 94, 5897–
5898. (b) Ireland, R. E.; Mueller, R. H.; Willard, A. K. J. Am. Chem. Soc.
1976, 98, 2868–2877.
(12) (a) Mizoroki, T.; Mori, K.; Ozaki, A. Bull. Chem. Soc. Jpn. 1971,
44, 581. (b) Heck, R. F.; Nolley, J. P. J. Org. Chem. 1972, 37, 2320–2322.
Org. Lett., Vol. 12, No. 19, 2010
4225